remember - there is no downside risk in investing in cris (just kidding)
i am really surprised that this is not an $8 stock now (same)
now the google board is predictably fighting amongst themselves. there are the usual bashers, but there is at least one member who is objective and the board still can't handle it. this is typical when people are losing a ton of money.
i'm hoping that the triple trial shows that a subset of pancreatic adeno patients respond exceedingly well with vis added. hope to hear in december. again, i expect the gem/abraxane trial to show great results.